A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults
Clinical trial NCT06494527 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06494527
- Sponsor
- Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-18
- Primary completion
- 2026-08-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.